...
search icon
ptct-img

PTC Therapeutics Inc Share Price

PTCT
NSQ
$73.09
-$0.82
(-1.11%)
1D
Industry: Biotechnology Sector: Health Care

PTC Therapeutics Inc Analyst Forecast

PTC Therapeutics Inc Share Price Chart

PTC Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.93B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
8.7113
Volume info-icon
This is the total number of shares traded during the most recent trading day.
231.72K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.49
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$35.95 L
$87.5 H
$73.09

About PTC Therapeutics Inc, Common Stock

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey. more

Industry: BiotechnologySector: Health Care

PTC Therapeutics Inc Stock Returns

Time FramePTCTSectorS&P500
1-Week Return-2.24%1.11%-1.36%
1-Month Return-3.71%0.64%-0.25%
3-Month Return9.14%7.53%1.6%
6-Month Return41.45%17.31%8.75%
1-Year Return49.68%6.11%14.02%
3-Year Return59.87%18.25%67.5%
5-Year Return17.17%35.14%77.71%
10-Year Return176.82%137.56%259.27%

PTC Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue380.77M538.59M698.80M937.82M806.78M[{"date":"2020-12-31","value":40.6,"profit":true},{"date":"2021-12-31","value":57.43,"profit":true},{"date":"2022-12-31","value":74.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.03,"profit":true}]
Cost of Revenue18.94M32.33M44.68M65.49M57.40M[{"date":"2020-12-31","value":28.93,"profit":true},{"date":"2021-12-31","value":49.37,"profit":true},{"date":"2022-12-31","value":68.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":87.65,"profit":true}]
Gross Profit361.82M506.26M654.12M872.34M749.38M[{"date":"2020-12-31","value":41.48,"profit":true},{"date":"2021-12-31","value":58.04,"profit":true},{"date":"2022-12-31","value":74.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":85.91,"profit":true}]
Gross Margin95.03%94.00%93.61%93.02%92.89%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.92,"profit":true},{"date":"2022-12-31","value":98.51,"profit":true},{"date":"2023-12-31","value":97.89,"profit":true},{"date":"2024-12-31","value":97.75,"profit":true}]
Operating Expenses793.59M880.71M1.10B1.31B1.05B[{"date":"2020-12-31","value":60.49,"profit":true},{"date":"2021-12-31","value":67.14,"profit":true},{"date":"2022-12-31","value":83.97,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":80.19,"profit":true}]
Operating Income(431.77M)(374.44M)(447.41M)(439.50M)(302.57M)[{"date":"2020-12-31","value":-43176800000,"profit":false},{"date":"2021-12-31","value":-37444300000,"profit":false},{"date":"2022-12-31","value":-44740900000,"profit":false},{"date":"2023-12-31","value":-43950200000,"profit":false},{"date":"2024-12-31","value":-30257000000,"profit":false}]
Total Non-Operating Income/Expense(27.52M)(229.92M)(230.95M)(366.01M)(227.54M)[{"date":"2020-12-31","value":-2751600000,"profit":false},{"date":"2021-12-31","value":-22991900000,"profit":false},{"date":"2022-12-31","value":-23094900000,"profit":false},{"date":"2023-12-31","value":-36601300000,"profit":false},{"date":"2024-12-31","value":-22754200000,"profit":false}]
Pre-Tax Income(402.93M)(518.34M)(587.49M)(696.11M)(363.12M)[{"date":"2020-12-31","value":-40293200000,"profit":false},{"date":"2021-12-31","value":-51834000000,"profit":false},{"date":"2022-12-31","value":-58748700000,"profit":false},{"date":"2023-12-31","value":-69611000000,"profit":false},{"date":"2024-12-31","value":-36311900000,"profit":false}]
Income Taxes35.23M5.56M(28.47M)(69.51M)176.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":15.79,"profit":true},{"date":"2022-12-31","value":-80.82,"profit":false},{"date":"2023-12-31","value":-197.3,"profit":false},{"date":"2024-12-31","value":0.5,"profit":true}]
Income After Taxes(438.16M)(523.90M)(559.02M)(626.60M)(363.30M)[{"date":"2020-12-31","value":-43816000000,"profit":false},{"date":"2021-12-31","value":-52390100000,"profit":false},{"date":"2022-12-31","value":-55901700000,"profit":false},{"date":"2023-12-31","value":-62660400000,"profit":false},{"date":"2024-12-31","value":-36329500000,"profit":false}]
Income From Continuous Operations(438.16M)(523.90M)(559.02M)(641.70M)(363.30M)[{"date":"2020-12-31","value":-43816000000,"profit":false},{"date":"2021-12-31","value":-52390100000,"profit":false},{"date":"2022-12-31","value":-55901700000,"profit":false},{"date":"2023-12-31","value":-64170100000,"profit":false},{"date":"2024-12-31","value":-36329500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(438.16M)(523.90M)(559.02M)(626.60M)(363.30M)[{"date":"2020-12-31","value":-43816000000,"profit":false},{"date":"2021-12-31","value":-52390100000,"profit":false},{"date":"2022-12-31","value":-55901700000,"profit":false},{"date":"2023-12-31","value":-62660400000,"profit":false},{"date":"2024-12-31","value":-36329500000,"profit":false}]
EPS (Diluted)(6.54)(7.43)(7.33)(6.54)(4.20)[{"date":"2020-12-31","value":-654,"profit":false},{"date":"2021-12-31","value":-743,"profit":false},{"date":"2022-12-31","value":-733,"profit":false},{"date":"2023-12-31","value":-654,"profit":false},{"date":"2024-12-31","value":-420.16,"profit":false}]

PTC Therapeutics Inc Ratios

PTC Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

PTCT
Cash Ratio 1.97
Current Ratio 2.32
Quick Ratio 2.26

PTC Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PTCT
ROA (LTM) 25.70%
ROE (LTM) -7740.12%

PTC Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PTCT
Debt Ratio Lower is generally better. Negative is bad. 1.06
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.06

PTC Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PTCT
Trailing PE 8.71
Forward PE 6.01
P/S (TTM) 3.38
P/B 1743.27
Price/FCF NM
EV/R 2.66
EV/Ebitda 5.19
PEG 0.81

FAQs

What is PTC Therapeutics Inc share price today?

PTC Therapeutics Inc (PTCT) share price today is $73.09

Can Indians buy PTC Therapeutics Inc shares?

Yes, Indians can buy shares of PTC Therapeutics Inc (PTCT) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PTCT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of PTC Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of PTC Therapeutics Inc (PTCT) via the Vested app. You can start investing in PTC Therapeutics Inc (PTCT) with a minimum investment of $1.

How to invest in PTC Therapeutics Inc shares from India?

You can invest in shares of PTC Therapeutics Inc (PTCT) via Vested in three simple steps:

  • Click on Sign Up or Invest in PTCT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in PTC Therapeutics Inc shares
What is PTC Therapeutics Inc 52-week high and low stock price?

The 52-week high price of PTC Therapeutics Inc (PTCT) is $87.5. The 52-week low price of PTC Therapeutics Inc (PTCT) is $35.95.

What is PTC Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of PTC Therapeutics Inc (PTCT) is 8.7113

What is PTC Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of PTC Therapeutics Inc (PTCT) is 1743.27

What is PTC Therapeutics Inc dividend yield?

The dividend yield of PTC Therapeutics Inc (PTCT) is 0.00%

What is the Market Cap of PTC Therapeutics Inc?

The market capitalization of PTC Therapeutics Inc (PTCT) is $5.93B

What is PTC Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of PTC Therapeutics Inc is PTCT

How Can Investors Use PTC Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of PTC Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether PTC Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from PTC Therapeutics Inc shares for Indian investors?

When investing in PTC Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the PTC Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare PTC Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of PTC Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that PTC Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top